APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 148 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $6,559,200 | +37.2% | 72,000 | +2.9% | 0.81% | -12.6% |
| Q3 2022 | $4,781,000 | +6.6% | 70,000 | -29.4% | 0.93% | +0.8% |
| Q2 2022 | $4,484,000 | +121.9% | 99,150 | +149.3% | 0.92% | +75.3% |
| Q1 2022 | $2,021,000 | -64.4% | 39,769 | -66.9% | 0.53% | -66.5% |
| Q4 2021 | $5,674,000 | -9.4% | 120,000 | -36.8% | 1.57% | -12.8% |
| Q3 2021 | $6,262,000 | +183.1% | 190,000 | +442.9% | 1.80% | +195.6% |
| Q2 2021 | $2,212,000 | -18.5% | 35,000 | -61.1% | 0.61% | -26.6% |
| Q3 2020 | $2,715,000 | +153.3% | 90,000 | +157.1% | 0.83% | +99.0% |
| Q4 2019 | $1,072,000 | – | 35,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |